Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
News|Articles|October 13, 2020
CPhI Announces 17th Annual CPhI Pharma Awards Winners
Author(s)Pharmaceutical Technology Editors
The winners were announced during day seven of CPhI Festival of Pharma.
Advertisement
CPhI Worldwide announced the winners of the 17th annual CPhI Pharma Awards on Oct. 13, 2020 during the virtual Festival of Pharma event. The shortlist consisted of 13 different categories spanning across the pharmaceutical supply chain and included a total of 83 finalists of the industry’s companies and individuals. Winners were selected by a panel of independent, senior industry experts.
The winners included:
Excellence in Pharma: Analysis, Testing, and Quality Control
Merck, Blazar platform
Excellence in Pharma: API Development
Micropore Technologies, Membrane Crystallisation
Excellence in Pharma: Contract Services and Outsourcing
Arcinova FlowInova
Excellence in Pharma: Finished Formulation
Lonza Capsugel, Capsugel DBcaps
Highly commended: Uriach Italy—Colpofix
Excellence in Pharma: Manufacturing Technology and Equipment
FabRx, M3DIMAKER
Excellence in Pharma: Drug Delivery Devices
Nemera Safe’n’Spray
Highly commended: Ypsomed, SmartPilot for YpsoMate
Excellence in Pharma: Packaging
SCHOTT Pharmaceutical Systems, SCHOTT Smart Containers
Excellence in Pharma: Regulatory Procedures and Compliance
Affygility Solutions, OEL Fastrac platform
Excellence in Pharma: Supply Chain, Logistics, and Distribution
Controlant, Cold Chain as a Service (ChaaS)
Excellence in Pharma: Digital Innovation
Novartis Pharma Schweiz, The Advanced Myelofibrosis Risk Scoring Tool
Excellence in Pharma: Sustainability
Dr. Reddy’s Laboratories, Watershed Program
Excellence in Pharma: CEO of the Year
Bobby Sheng, Bora Pharmaceuticals
Excellence in Pharma: Innovation in Response to COVID-19
Beximco Pharmaceuticals
Highly commended: Ridgeback Biotherapeutics, MK-4482—in collaboration with Merck
People’s choice—chosen by event attendees
MedPharm
Advertisement
Related to this article
Hovione's $35M CDC Flex line links spray drying to tablets, designed to eliminate scale-up under FDA Q13 guidance.
This week on PharmTech, Merck diversified its pipeline, USP emphasizes supply chain security, AI systems are examined, and speakers preview their presentations at CPHI Milan and AAPS PharmSci 360.
Capsugel's Bram Baert and Sandrine Picco argue that chasing zero nitrite in pharmaceutical excipients is often impractical and costly. They recommend setting scientifically justified, risk-based limits and consistently staying below them.
Ron Scarboro, Azurity Pharmaceuticals, claims drug reformulation that removes patient barriers must preserve efficacy, urging early cross-functional team alignment.
PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Advertisement
Advertisement